BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Basaranoglu M, Basaranoglu G, Sentürk H. From fatty liver to fibrosis: A tale of “second hit”. World J Gastroenterol 2013; 19(8): 1158-1165 [PMID: 23483818 DOI: 10.3748/wjg.v19.i8.1158]
URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1158.htm
(0) (0) (9422) (151)
Number Citing Articles
1
Pia S. Petersen, Xia Lei, Risa M. Wolf, Susana Rodriguez, Stefanie Y. Tan, Hannah C. Little, Michael A. Schweitzer, Thomas H. Magnuson, Kimberley E. Steele, G. William Wong. CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress. American Journal of Physiology-Endocrinology and Metabolism 2017; 312(4) doi: 10.1152/ajpendo.00344.2016
2
Christophe Desterke, Franck Chiappini. Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway. International Journal of Molecular Sciences 2019; 20(22) doi: 10.3390/ijms20225594
3
Zhixian Ding, Lusheng Wang, Jiting Sun, Lijie Zheng, Yu Tang, Heng Tang. Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1526206
4
Xia Li, Yongjuan Zhao, Hualan Zhou, Youdong Hu, Ying Chen, Dianxuan Guo. Cytokine and Oxidative Stress Imbalances in Relation to Complex Coronary Lesions in Elderly Patients. Current Vascular Pharmacology 2025; 23(6) doi: 10.2174/0115701611323165250211045917
5
Long-Xin Qiu, Tong Chen. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World Journal of Gastroenterology 2015; 21(4): 1099-1107 doi: 10.3748/wjg.v21.i4.1099
6
Kikuko Hotta, Takuya Kitamoto, Aya Kitamoto, Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Masato Yoneda, Kento Imajo, Wataru Tomeno, Satoru Saito, Atsushi Nakajima. Identification of the genomic region under epigenetic regulation during non‐alcoholic fatty liver disease progression. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12992
7
Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. Journal of Pharmacy and Pharmacology 2018; 70(3) doi: 10.1111/jphp.12870
8
Hermann-Georg Holzhütter, Nikolaus Berndt. Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD). Cells 2021; 10(3) doi: 10.3390/cells10030578
9
Chunxue Yang, Lin Zhu, Qingzheng Kang, Hin Kiu Lee, Dapeng Li, Arthur C.K. Chung, Zongwei Cai. Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice. Journal of Hazardous Materials 2019; 378 doi: 10.1016/j.jhazmat.2019.120766
10
Camila Sanches Manca, Lívia Maria Cordeiro Simões-Ambrosio, Paula Payão Ovídio, Leandra Zambelli Ramalho, Alceu Afonso Jordao, Chan‐Yen Kuo. Effects of Different Vegetable Oils on the Nonalcoholic Fatty Liver Disease in C57/BL Mice. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/4197955
11
Ju-Hwan Yang, Eun-Hye Byeon, Dawon Kang, Seong-Geun Hong, Jinsung Yang, Deok-Ryong Kim, Seung-Pil Yun, Sang-Won Park, Hyun-Joon Kim, Jae-Won Huh, So-Yong Kim, Young-Wan Kim, Dong-Kun Lee. Fermented Soybean Paste Attenuates Biogenic Amine-Induced Liver Damage in Obese Mice. Cells 2023; 12(5) doi: 10.3390/cells12050822
12
Usama Abbasi, Srinivas Abbina, Arshdeep Gill, Lily E. Takuechi, Jayachandran N. Kizhakkedathu. Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities. ACS Chemical Biology 2021; 16(6) doi: 10.1021/acschembio.1c00122
13
Yiyuan Xi, Jujia Zheng, Wei Xie, Xiangwei Xu, Namki Cho, Xudong Zhou, Xiaomin Yu. (+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.750147
14
Shubham Sharma, Anjali Sharma, Parul Gupta, Deepshi Arora, Geeta Deswal, Ajmer Grewal, Devkant Sharma. The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis. Cardiovascular & Hematological Disorders-Drug Targets 2025; 25(3) doi: 10.2174/011871529X360903250211101856
15
Colin T. Shearn, Kelly E. Mercer, David J. Orlicky, Leah Hennings, Rebecca L. Smathers-McCullough, Bangyan L. Stiles, Martin J. J. Ronis, Dennis R. Petersen, Michael Müller. Short Term Feeding of a High Fat Diet Exerts an Additive Effect on Hepatocellular Damage and Steatosis in Liver-Specific PTEN Knockout Mice. PLoS ONE 2014; 9(5) doi: 10.1371/journal.pone.0096553
16
Lingjuan Piao, Jiyeon Choi, Guideock Kwon, Hunjoo Ha. Endogenous catalase delays high-fat diet-induced liver injury in mice. The Korean Journal of Physiology & Pharmacology 2017; 21(3) doi: 10.4196/kjpp.2017.21.3.317
17
J. Schragenheim, O. Maayan, N. G. Abraham. Gasotransmitters. 2018;  doi: 10.1039/9781788013000-00059
18
Fengfeng Mo, Yuxiao Tang, Hui Shen, Lusha Wu, Qing Liu, Shuang Nie, Min Li, Chen Ling. HIF1α/miR-146α/TRAF6/NF-κB axis modulates hepatic iron overload-induced inflammation. The Journal of Nutritional Biochemistry 2024; 125 doi: 10.1016/j.jnutbio.2023.109499
19
Meiyu Jin, Haihua Feng, Yue Wang, Siru Yan, Bingyu Shen, Zheng Li, Haiyan Qin, Qi Wang, Jinxia Li, Guowen Liu. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/2940746
20
Ai‐rong Zhang, Jing Sun, Yuan He, Ning Wang, Li Tian. Attenuation of lipid accumulation in Bel‐7402 cells through ADPN/AMPKα signaling stimulated by Fructus rosae laxae extract. Journal of Food Biochemistry 2020; 44(12) doi: 10.1111/jfbc.13497
21
Zhanwei Yang, Jing Zhao, Jing'en Li, Jin Wang, Wenjun Wang. Genome-wide DNA methylation profiling of high-fat emulsion-induced hyperlipidemia mice intervened by a polysaccharide from Cyclocarya paliurus (Batal) Iljinskaja. Food and Chemical Toxicology 2021; 152 doi: 10.1016/j.fct.2021.112230
22
Joost Willebrords, Bruno Cogliati, Isabel Veloso Alves Pereira, Tereza Cristina da Silva, Sara Crespo Yanguas, Michaël Maes, Veronica Mollica Govoni, Andressa Lima, Daniele Aparecida Felisbino, Elke Decrock, Marina Sayuri Nogueira, Inar Alves de Castro, Isabelle Leclercq, Luc Leybaert, Robim Marcelino Rodrigues, Mathieu Vinken. Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08583-w
23
Xi Zhao, Jie Xue, Meilin Xie. Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes. Experimental Gerontology 2019; 119 doi: 10.1016/j.exger.2019.01.014
24
S.M.B. Duarte, J.T. Stefano, L. Miele, F.R. Ponziani, M. Souza-Basqueira, L.S.R.R. Okada, F.G. de Barros Costa, K. Toda, D.F.C. Mazo, E.C. Sabino, F.J. Carrilho, A. Gasbarrini, C.P. Oliveira. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutrition, Metabolism and Cardiovascular Diseases 2018; 28(4) doi: 10.1016/j.numecd.2017.10.014
25
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108 doi: 10.1007/978-3-319-89390-7_10
26
Kexin Lian, Qiming Fan, Sufang Sheng, Kexin Zhang, Xiaodong Sun, Chengxia Kan, Ruiyan Pan, Zhentao Guo. Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: Unraveling Connections and Advancing Therapies. Bratislava Medical Journal 2025; 126(8) doi: 10.1007/s44411-025-00189-3
27
Changhui Yu, Shiming He, Nan Peng, Maobin Kuang, Xin Huang, Chao Wang, Guotai Sheng, Wei Wang, Guobo Xie, Yang Zou. The fasting plasma glucose to high-density lipoprotein cholesterol ratio: a novel index for identifying NAFLD. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03831-0
28
Arun Baidya, Indrani Ghosh, Shuvam Sar, Tanmoy Banerjee, Ankit Kumar, Saptapadi Saha, Rituparna Chaki, Amit Kumar Halder, Nilanjan Ghosh. Nanobiomaterials and Nanomedicines for Metabolic Disorders. 2026;  doi: 10.1016/B978-0-443-28942-2.00007-7
29
Hongguang Xia, Xiangyu Zhu, Xiaoyan Zhang, Haiyan Jiang, Biao Li, Zhihao Wang, Dalang Li, Yong Jin. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. Biomedicine & Pharmacotherapy 2019; 118 doi: 10.1016/j.biopha.2019.109287
30
Xiaoqian Hu, Yinuo Wang, Guangming Jiang, Ying Lu, Yujie Shu, Shuo Zhang, Yuting Zhu, Yongxiang Wu, Liping Wu, Jian Wang, Yaping Wang, Wei Li, Shufeng Bi. Alleviation of hyperlipidemia by peptides from a fermented soybean product via regulating the expression of lipid metabolism-related mRNAs and enzymes. Applied Food Research 2026; 6(1) doi: 10.1016/j.afres.2026.102115
31
Xi Zhao, Feng Wang, Ruijun Zhou, Zengyan Zhu, Meilin Xie. PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats. Inflammopharmacology 2018; 26(2) doi: 10.1007/s10787-017-0327-2
32
Luping Zhou, Lulu Chen, Xiangchang Zeng, Jianwei Liao, Dongsheng Ouyang. Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis. Toxicology and Applied Pharmacology 2020; 386 doi: 10.1016/j.taap.2019.114829
33
David Ipsen, Pernille Tveden-Nyborg, Jens Lykkesfeldt. Does Vitamin C Deficiency Promote Fatty Liver Disease Development?. Nutrients 2014; 6(12) doi: 10.3390/nu6125473
34
A. Drori, D. Rotnemer-Golinkin, S. Avni, A. Drori, O. Danay, D. Levanon, J. Tam, L. Zolotarev, Y. Ilan. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0688-4
35
В. П. Присяжнюк, О. І. Волошин. Клінічно-патоґенетичні, вікові, ґендерні, ґенетичні аспекти неалкогольної жирової хвороби печінки та хронічного гепатиту невірусного походження без і з коморбідним гіпотирозом; удосконалення їх лікування. Lviv clinical bulletin 2018; (3 (23)) doi: 10.25040/lkv2018.03.008
36
Tehila Daniel, Michaella Ben-Shachar, Elyashiv Drori, Sharleen Hamad, Anna Permyakova, Elad Ben-Cnaan, Joseph Tam, Zohar Kerem, Tovit Rosenzweig. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. The Journal of Nutritional Biochemistry 2021; 98 doi: 10.1016/j.jnutbio.2021.108867
37
F. Xia, L. Zeng, X.R. Yao, B.J. Zhou. Liver Pathophysiology. 2017;  doi: 10.1016/B978-0-12-804274-8.00003-5
38
Bao Tung Pham, Wouter Tobias van Haaften, Dorenda Oosterhuis, Judith Nieken, Inge Anne Maria de Graaf, Peter Olinga. Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiological Reports 2015; 3(4) doi: 10.14814/phy2.12323
39
Zhongwen Feng, Lijun Pang, Siyun Chen, Xiaohong Pang, Yushen Huang, Qian Qiao, Yinglian Wang, Sayyaphone Vonglorkham, Quanfang Huang, Xing Lin, Jinbin Wei. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. International Immunopharmacology 2020; 88 doi: 10.1016/j.intimp.2020.107003
40
Meagan Rose, Martin Veysey, Mark Lucock, Suzanne Niblett, Katrina King, Surinder Baines, Manohar L. Garg. Association between erythrocyte omega-3 polyunsaturated fatty acid levels and fatty liver index in older people is sex dependent. Journal of Nutrition & Intermediary Metabolism 2016; 5 doi: 10.1016/j.jnim.2016.04.007
41
Ning Wang, Xiajing Li, Zhiyong Zhong, Yaqi Qiu, Shoupei Liu, Haibin Wu, Xianglian Tang, Chuxin Chen, Yingjie Fu, Qicong Chen, Tingting Guo, Jinsong Li, Shuai Zhang, Mark A. Zern, Keqiang Ma, Bailin Wang, Yimeng Ou, Weili Gu, Jie Cao, Honglin Chen, Yuyou Duan. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01138-2
42
Nina Graffmann, Sarah Ring, Marie-Ann Kawala, Wasco Wruck, Audrey Ncube, Hans-Ingo Trompeter, James Adjaye. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha. Stem Cells and Development 2016; 25(15) doi: 10.1089/scd.2015.0383
43
Zineb Benzait, Özlem Tomsuk, Aliakbar Ebrahimi, Hamed Ghorbanpoor, Ceren Özel, Reza Didarian, Bahar Demir Cevizlidere, Murat Kaya, Tamer Gur, Nigar Gasimzade, Fulya Büge Ergen, Ahmet Emin Topal, Shadab Dabagh, Roshan Javanifar, Nuran Abdullayeva, Onur Uysal, Ayla Eker Sarıboyacı, Fatma Doğan Güzel, Shabir Hassan, Huseyin Avci. Liver-on-a-Chip (LoC) Models: Case Studies of Academic Platforms and Commercial Products. Molecular Pharmaceutics 2026; 23(3) doi: 10.1021/acs.molpharmaceut.5c01122
44
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7) doi: 10.1038/nrgastro.2016.85
45
Nixi Huang, Lina Peng, Enhui Huang, Ying Qin, Hongjie Li, Jiangrui Liao, Yu Wang, Lei Shi, Lili Sun. Apigenin combined with aerobic exercise alleviates oxidative stress and inflammation in high-fat diet-induced NAFLD mice by modulating the Keap1/Nrf2/ARE pathway. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-45268-9
46
Huifang Gao, Yaru Cao, Hongguang Xia, Xiangyu Zhu, Yong Jin. CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation . International Journal of Molecular Medicine 2020;  doi: 10.3892/ijmm.2020.4479
47
Nghia Nhu Nguyen, Bao The Nguyen, Huyen Thi Ngoc Le, Hoang Nhat Dang, Hao Minh Pham, Duong Dai Ngo, Duy Khanh Tran Nguyen, Tam Thai Thanh Tran, Hung Thanh Kim, Tan Ngoc Huynh Mai. The simple multivariable model for predicting liver fibrosis in Vietnamese male adults: a combination of Bayesian model averaging and stepwise method. PeerJ 2026; 14 doi: 10.7717/peerj.20435
48
嘉璐 陈. Study of Gut Microbiota in Metabolic Dysfunction-Associated Fatty Liver Disease. Advances in Clinical Medicine 2026; 16(04) doi: 10.12677/acm.2026.1641354
49
Sandra Milic, Ivana Mikolasevic, Lidija Orlic, Edita Devcic, Nada Starcevic-Cizmarevic, Davor Stimac, Miljenko Kapovic, Smiljana Ristic. The Role of Iron and Iron Overload in Chronic Liver Disease. Medical Science Monitor 2016; 22 doi: 10.12659/MSM.896494
50
Cynthia L. Vuittonet, Michael Halse, Lorenzo Leggio, Samuel B. Fricchione, Michael Brickley, Carolina L. Haass-Koffler, Tonya Tavares, Robert M. Swift, George A. Kenna. Pharmacotherapy for alcoholic patients with alcoholic liver disease. American Journal of Health-System Pharmacy 2014; 71(15) doi: 10.2146/ajhp140028
51
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
52
Rustu Turkay, Abdurrahman Fatih Aydin, Ilknur Bingul, Canan Kucukgergin, Isin Dogan-Ekici, Elif Hocaoglu, Ercan Inci, Baris Bakir, Mujdat Uysal. Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?. Ultrasound Quarterly 2017; 33(2) doi: 10.1097/RUQ.0000000000000286
53
Colin T. Shearn, Laura M. Saba, James R. Roede, David J. Orlicky, Alisabeth H. Shearn, Dennis R. Petersen. Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. Free Radical Biology and Medicine 2017; 113 doi: 10.1016/j.freeradbiomed.2017.10.004
54
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/3870454
55
Jelte J. Schaapman, Maarten E. Tushuizen, Minneke J. Coenraad, Hildo J. Lamb. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. Journal of Magnetic Resonance Imaging 2021; 53(6) doi: 10.1002/jmri.27292
56
Flavia A Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, Sergio Morini. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(19): 3407-3417 doi: 10.3748/wjg.v23.i19.3407
57
Wanpeng Lu, Jinyu Mei, Juan Yang, Zhihan Wu, Jiayuan Liu, Pengyu Miao, Yiliang Chen, Zhenfan Wen, Zhongting Zhao, Hua Kong, Chao Wu, Yan Yang, Ming Chen. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy. Life Sciences 2020; 252 doi: 10.1016/j.lfs.2020.117601
58
Terry D. Hinds, Komal Sodhi, Charles Meadows, Larisa Fedorova, Nitin Puri, Dong Hyun Kim, Stephen J. Peterson, Joseph Shapiro, Nader G. Abraham, Attallah Kappas. Retracted: Increased HO‐1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity 2014; 22(3) doi: 10.1002/oby.20559
59
Metin Basaranoglu, Alev Kurtoglu. Replacing the Name of NAFLD With a Metabolic or Another Forename as Indicator of the Era of Stagnation in NASH Studies. Journal of Clinical Gastroenterology 2021; 55(6) doi: 10.1097/MCG.0000000000001494
60
Elham Nazari, Ghazaleh Khalili-Tanha, Alireza Asadnia, Ghazaleh Pourali, Mina Maftooh, Majid Khazaei, Mohammadreza Nasiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad Ali Kiani, Amir Avan. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46711-x
61
Mahyar Mohammadifard, Zeinab Saremi, Mahboobe Rastgoo, Ehsan Akbari. Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran. Journal of Medicine and Life 2019; 12(2) doi: 10.25122/jml-2019-0012
62
Taynã Cristina Tiburcio, Joost Willebrords, Tereza Cristina da Silva, Isabel Veloso Alves Pereira, Marina Sayuri Nogueira, Sara Crespo Yanguas, Michaël Maes, Elisangela dos Anjos Silva, Maria Lucia Zaidan Dagli, Inar Alves de Castro, Cláudia Pinto Oliveira, Mathieu Vinken, Bruno Cogliati. Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non‐alcoholic steatohepatitis. Clinical and Experimental Pharmacology and Physiology 2017; 44(2) doi: 10.1111/1440-1681.12701
63
Jamie Cheung, Bernard Man-Yung Cheung, Kai-Hang Yiu, Hung-Fat Tse, Yap-Hang Chan. Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects. Frontiers in Cardiovascular Medicine 2025; 12 doi: 10.3389/fcvm.2025.1573841
64
Shenghu Zhu, Linshu Guan, Xuemei Tan, Guoquan Li, Changjie Sun, Meng Gao, Bao Zhang, Lina Xu. Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.585582
65
Katharina Brandl, Bernd Schnabl. The Human Microbiota and Chronic Disease. 2016;  doi: 10.1002/9781118982907.ch22
66
Dennis R. Petersen, Laura M. Saba, Volkan I. Sayin, Thales Papagiannakopoulos, Edward E. Schmidt, Gary F. Merrill, David J. Orlicky, Colin T. Shearn, Manlio Vinciguerra. Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice. PLOS ONE 2018; 13(5) doi: 10.1371/journal.pone.0198139
67
Irene Besné-Eseverri, María Ángeles Martín, Gloria Lobo, M. Pilar Cano, María P. Portillo, Jenifer Trepiana. Antioxidant and Anti-Inflammatory Effects of Opuntia Extracts on a Model of Diet-Induced Steatosis. Antioxidants 2024; 13(11) doi: 10.3390/antiox13111416
68
Yiyi Jin, Zhaoshui Shangguan, Jiao Pang, Yuwen Chen, Suijin Lin, Hekun Liu. Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115822
69
Ehsan Arabzadeh, Amir Sarshin, Foad Feizolahi, Majid Mohabbat, Mohammad-Ali Soleiman-Fallah, Alireza Rahimi, Anatoli Petridou, Zahra Emami, Helena Tajik, Reza Bozorg Omid, Amir Maleki, Hamid Ekrami Ogholbag, Ali Khademi, Mehdi Zargani. Synergistic salvation: HIIT and herbal allies reverse NAFLD damage in rats. Journal of Molecular Histology 2025; 56(2) doi: 10.1007/s10735-025-10413-7
70
Yuhua Xue, Tian Tian, Melak Ottallah, Mahfuza Mannan, Joshua Barkin, Brady Jin-Smith, Liya Pi. Alcohol-Associated Hepatocarcinogenesis. The American Journal of Pathology 2026; 196(1) doi: 10.1016/j.ajpath.2025.04.016
71
Neveen Rashad Mostafa, Abeer A.M. Ali, Mona Gamalludin Alkaphoury, Roy Rillera Marzo. <i>Helicobacter Pylori</i> infection and non-alcoholic fatty liver disease. Is there a relationship?. Healthcare in Low-resource Settings 2023; 11(1) doi: 10.4081/hls.2023.11379
72
Atsuo Tahara, Toshiyuki Takasu. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice. Endocrine Research 2020; 45(2) doi: 10.1080/07435800.2020.1713802
73
G Teixeira, C Szyndralewiez, S Molango, S Carnesecchi, F Heitz, P Wiesel, J M Wood. Therapeutic potential of NADPH oxidase 1/4 inhibitors. British Journal of Pharmacology 2017; 174(12) doi: 10.1111/bph.13532
74
Hend A. Essa, Abeer E. El-Metwally, Nadia A. Elkady. The potential protective effects of fermented extra virgin olive oil on high-fructose diet-induced non-alcoholic steatohepatitis in rats. Food Production, Processing and Nutrition 2025; 7(1) doi: 10.1186/s43014-025-00320-5
75
Masanobu Kimura, Yuriko Saiki, Kosei Iwata, Keigo Murakami, Toru Furukawa. Dual-specificity phosphatase 6 interferes with the repressive activity of forkhead box O1 towards CYP4A11 that mediates lipid accumulation in the liver. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-35118-z
76
Iala Milene Bertasso, Carla Bruna Pietrobon, Rosane Aparecida Ribeiro, Gabriela Moreira Soares, Janaina Chaves de Oliveira, Ana Claudia Paiva Alegre-Maller, Antonio Carlos Boschero, Allan Cezar Faria Araújo, Ana Tereza Bittencourt Guimarães, Maria Lúcia Bonfleur, Sandra Lucinei Balbo. Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic de novo lipogenesis in offspring. Journal of Developmental Origins of Health and Disease 2022; 13(2) doi: 10.1017/S2040174421000271
77
Xin Chu, Qunyan Jin, Hui Chen, G. Craig Wood, Anthony Petrick, William Strodel, Jon Gabrielsen, Peter Benotti, Tooraj Mirshahi, David J. Carey, Christopher D. Still, Johanna K. DiStefano, Glenn S. Gerhard. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1490-y
78
Ying-Chun Wang, Wei-Zong Kong, Qing-Mei Jin, Juan Chen, Lei Dong. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World Journal of Gastroenterology 2015; 21(35): 10104-10112 doi: 10.3748/wjg.v21.i35.10104
79
Metin Basaranoglu. Lean and Nonobese NAFLD/NASH From a Hepatologist’s Point of View. Journal of Clinical Gastroenterology 2021; 55(1) doi: 10.1097/MCG.0000000000001428
80
Pooja Yadav, Khushi Quadri, Renu Kadian, Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam. New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products. iLIVER 2024; 3(4) doi: 10.1016/j.iliver.2024.100131
81
Christopher R. Day, Stephen A. Kempson. Betaine chemistry, roles, and potential use in liver disease. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(6) doi: 10.1016/j.bbagen.2016.02.001
82
Yushuang Wei, Mengzhu Zhao, Fang Yang, Yang Mao, Hang Xie, Qibing Zhou. Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment. Scientific Reports 2016; 6(1) doi: 10.1038/srep29110
83
Gang Cheng, Arun P. Palanisamy, Zachary P. Evans, Alton G. Sutter, Lan Jin, Inderjit Singh, Harold May, Michael G. Schmidt, Kenneth D. Chavin, Rajesh Mohanraj. Cerulenin Blockade of Fatty Acid Synthase Reverses Hepatic Steatosis in ob/ob Mice. PLoS ONE 2013; 8(9) doi: 10.1371/journal.pone.0075980
84
Engy A. Aboulwafa, Doaa M. Shawky, Ahmed Farag Seddik. A Transfer Learning Approach for the Automatic Detection of Fatty Liver from Ultrasound Images. 2021 11th International Conference on Advanced Computer Information Technologies (ACIT) 2021;  doi: 10.1109/ACIT52158.2021.9548566
85
Fang‐tian Bu, Ao Wang, Yan Zhu, Hong‐mei You, Ya‐fei Zhang, Xiao‐ming Meng, Cheng Huang, Jun Li. LncRNANEAT1: Shedding light on mechanisms and opportunities in liver diseases. Liver International 2020; 40(11) doi: 10.1111/liv.14629
86
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. Nutrients 2017; 9(10) doi: 10.3390/nu9101065
87
Sławomir Dariusz Szajda, Jacek Dobryniewski, Alina Minarowska, Jadwiga Snarska, Napoleon Waszkiewicz, Krzysztof Zwierz. The Effect of Neoglandin on the Activity of N-Acetyl-β-D-Hexosaminidase in the Serum and Urine of Alcohol-Dependent Men. International Journal of Environmental Research and Public Health 2023; 20(4) doi: 10.3390/ijerph20043413
88
Ryan E. Feaver, Banumathi K. Cole, Mark J. Lawson, Stephen A. Hoang, Svetlana Marukian, Brett R. Blackman, Robert A. Figler, Arun J. Sanyal, Brian R. Wamhoff, Ajit Dash. Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight 2016; 1(20) doi: 10.1172/jci.insight.90954
89
Seren Ozenirler, Gulbanu Erkan, Ceyla Konca Degertekin, Ugur Ercin, Mustafa Cengiz, Ayse Bilgihan, Guldal Yilmaz, Gulen Akyol. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis. Journal of Digestive Diseases 2014; 15(3) doi: 10.1111/1751-2980.12113
90
Javier López-Prieto, Emilio González-Reimers, M. Remedios Alemán-Valls, María José de la Vega-Prieto, Pedro Abreu-González, Ricardo Pelazas-González, Rubén Hernández-Luis, Carlos Jorge-Ripper, Francisco Santolaria-Fernández. Iron and Proinflammatory Cytokines in Chronic Hepatitis C Virus Infection. Biological Trace Element Research 2013; 155(1) doi: 10.1007/s12011-013-9760-2
91
Metin Basaranoglu, Sonia M Najjar, Ali Ebag Demirbag, Hakan Senturk. Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World Journal of Hepatology 2016; 8(7): 376-384 doi: 10.4254/wjh.v8.i7.376
92
Ya-yun Liu, Jiao-jiao You, Wei Xu, Ting Zhai, Chun-yuan Du, Yong Chen, Feng-mei Han. Gynura procumbens aqueous extract alleviates nonalcoholic steatohepatitis through CFLAR-JNK pathway in vivo and in vitro. Chinese Herbal Medicines 2019; 11(4) doi: 10.1016/j.chmed.2019.09.005
93
Chuang Zhu, Qi Guan, Chenwei Song, Lingyue Zhong, Xinwen Ding, Hui Zeng, Pan Nie, Lihua Song. Regulatory effects of Lactobacillus fermented black barley on intestinal microbiota of NAFLD rats. Food Research International 2021; 147 doi: 10.1016/j.foodres.2021.110467
94
Kaiyue Wang, Wangxiao Tan, Xiao Liu, Lina Deng, Lu Huang, Xiaoying Wang, Xiumei Gao. New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. Biomedicine & Pharmacotherapy 2021; 137 doi: 10.1016/j.biopha.2021.111326
95
M. O. Chyzh, I. V. Koshurba, M. M. Marchenko, F. V. Hladkykh, I. V. Belochkina. Gender determinism of the effect of placenta cryoextract on the hepatotropic effects of esomeprazole, clarithromycin and metronidazole in chronic liver damage. Modern medical technology 2023; (1) doi: 10.34287/MMT.1(56).2023.9
96
Liyun Wang, Kahua Liu, Liang Deng, Guanyu Zhou, Wei Qian, Keshu Xu. Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease. Applied Biochemistry and Biotechnology 2024; 196(6) doi: 10.1007/s12010-023-04694-5
97
Ziyang Li, Chaoliang Xiong, Suo Mo, Haiying Tian, Mengqian Yu, Tingting Mao, Qian Chen, Haitao Luo, Quanzhen Li, Jianxin Lu, Yi Zhao, Wei Li, Yu Xue. Comprehensive Transcriptome Analyses of the Fructose-Fed Syrian Golden Hamster Liver Provides Novel Insights into Lipid Metabolism. PLOS ONE 2016; 11(9) doi: 10.1371/journal.pone.0162402
98
E. Chávez, M. Galicia-Moreno, P. Muriel. Liver Pathophysiology. 2017;  doi: 10.1016/B978-0-12-804274-8.00052-7
99
Sizhao Lu, Robert G Bennett, Kusum K Kharbanda, Duygu Dee Harrison-Findik. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World Journal of Hepatology 2016; 8(4): 211-225 doi: 10.4254/wjh.v8.i4.211
100
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4) doi: 10.1007/s00210-015-1207-1
101
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver Cancer. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23168846
102
Ting Zhai, Wei Xu, Yayun Liu, Kun Qian, Yanling Xiong, Yong Chen, Tullia Maraldi. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/2313641
103
Nina Graffmann, Lucas-Sebastian Spitzhorn, Audrey Ncube, Wasco Wruck, James Adjaye. Essential Current Concepts in Stem Cell Biology. Learning Materials in Biosciences 2020;  doi: 10.1007/978-3-030-33923-4_11
104
Chongli Xu, Yu Liu, Yuchen Gong, Xinping Duan, Xiaochun Tang, Mingjun Zhang, Daxin Pang, Liqing Yu, Hong Wei, Hongsheng Ouyang. Overexpression of NPC1L1 in the livers of transgenic Bama miniature pigs accelerates lipid peroxidation. Genes & Genomics 2015; 37(2) doi: 10.1007/s13258-014-0235-4
105
Lijia Zhang, Xuezheng Dai, Li Wang, Jingming Cai, Jie Shen, Yang Shen, Xianan Li, Yan Zhao. Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.961892
106
Ya-nan Wang, Shiyue Liu. The role of ALDHs in lipid peroxidation-related diseases. International Journal of Biological Macromolecules 2025; 288 doi: 10.1016/j.ijbiomac.2024.138760
107
María José Monedero-Prieto, José María González-Pérez, Emilio González-Reimers, Onán Hernández-Pérez, María Monereo-Muñoz, Luis Galindo-Martín, Geraldine Quintero-Platt, Pedro Abreu-González. Effects of Selenium on Liver and Muscle Contents and Urinary Excretion of Zinc, Copper, Iron and Manganese. Biological Trace Element Research 2014; 158(2) doi: 10.1007/s12011-014-9928-4
108
Yiqiong Sun, Fuping Li, Weizhen Hua, Zhenbin Che, Meiping Tian, Yan-Yang Lu, Qingyu Huang. Identifying biomarkers for arsenic exposure-induced nonalcoholic fatty liver disease: An integrated proteomics, metabolomics, and machine learning approach. Journal of Hazardous Materials 2025; 500 doi: 10.1016/j.jhazmat.2025.140485
109
Noha A. El-Boghdady, Maher A. Kamel, Rouaina M. El-Shamy. Omeprazole and Spirulina Platensis Ameliorate Steatohepatitis in Experimental Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2020; 18(9) doi: 10.1089/met.2019.0129
110
Masuko Kobori, Yinhua Ni, Yumiko Takahashi, Natsumi Watanabe, Minoru Sugiura, Kazunori Ogawa, Mayumi Nagashimada, Shuichi Kaneko, Shigehiro Naito, Tsuguhito Ota, Marcia B. Aguila. β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice. PLoS ONE 2014; 9(5) doi: 10.1371/journal.pone.0098294
111
Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. PLOS ONE 2021; 16(11) doi: 10.1371/journal.pone.0260313
112
Hilmar K L&uuml;ckhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
113
Thing-Fong Tzeng, Yu-Cheng Tzeng, Yu-Jou Cheng, Shorong-Shii Liou, I-Min Liu. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model. Nutrients 2015; 7(10) doi: 10.3390/nu7105423
114
Sevda Tanrıkulu-Küçük, Canan Başaran-Küçükgergin, Muhammed Seyithanoğlu, Semra Doğru-Abbasoğlu, Hikmet Koçak, Şule Beyhan-Özdaş, Yıldız Öner-İyidoğan. Effect of dietary curcumin and capsaicin on testicular and hepatic oxidant–antioxidant status in rats fed a high-fat diet. Applied Physiology, Nutrition, and Metabolism 2019; 44(7) doi: 10.1139/apnm-2018-0622
115
Ayala Wollman, Tehila Daniel, Tovit Rosenzweig. Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice. Nutrients 2019; 11(12) doi: 10.3390/nu11123044
116
Colin T. Shearn, Blair Fennimore, David J. Orlicky, Yue R. Gao, Laura M. Saba, Kayla D. Battista, Stefanos Aivazidis, Mohammed Assiri, Peter S. Harris, Cole Michel, Gary F. Merrill, Edward E. Schmidt, Sean P. Colgan, Dennis R. Petersen. Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response. Free Radical Biology and Medicine 2019; 143 doi: 10.1016/j.freeradbiomed.2019.07.036
117
Joseph Tawai, Jing Xiong. Technology-enabled insights into SLC transporters in MAFLD: redefining the multi-hit pathogenesis and therapeutic landscape. Acta Pharmacologica Sinica 2026; 47(7) doi: 10.1038/s41401-026-01756-2
118
Yayun Liu, Qingqing Yu, Yong Chen. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells. Biomedicine & Pharmacotherapy 2018; 108 doi: 10.1016/j.biopha.2018.09.089
119
Qing Peng, Liyuan Hao, Shenghao Li, Fei Yu, Na Li, Xiaoyu Hu. A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1640873
120
Zhuhuang Zhou, Jui Fang, Anca Cristea, Ying-Hsiu Lin, Yu-Wei Tsai, Yung-Liang Wan, Kee-Min Yeow, Ming-Chih Ho, Po-Hsiang Tsui. Value of homodyned K distribution in ultrasound parametric imaging of hepatic steatosis: An animal study. Ultrasonics 2020; 101 doi: 10.1016/j.ultras.2019.106001
121
Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
122
Yoojin Lee, Ji-Young Lee. Dietary Interventions in Liver Disease. 2019;  doi: 10.1016/B978-0-12-814466-4.00008-2
123
Si-Si Jin, Xian-Fan Lin, Ju-Zeng Zheng, Qiong Wang, Hua-Qin Guan. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3. European Cytokine Network 2019; 30(3) doi: 10.1684/ecn.2019.0432
124
Byoung-Joon Song, Mohammed Akbar, Mohamed A. Abdelmegeed, Kyunghee Byun, Bonghee Lee, Seung Kew Yoon, James P. Hardwick. Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biology 2014; 3 doi: 10.1016/j.redox.2014.10.004
125
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology. 2017;  doi: 10.1016/B978-0-12-804274-8.00053-9
126
Valéria Nunes-Souza, Cheila Juliana César-Gomes, Lucas José Sá Da Fonseca, Glaucevane Da Silva Guedes, Salete Smaniotto, Luíza Antas Rabelo, Vladimir Jakovljevic. Aging Increases Susceptibility to High Fat Diet‐Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/1987960
127
Zeping Huang, Jian Zheng, Jie Zeng, Xiaoli Wang, Tao Wu, Rongqin Zheng. Normal Liver Stiffness in Healthy Adults Assessed By Real-Time Shear Wave Elastography and Factors That Influence This Method. Ultrasound in Medicine & Biology 2014; 40(11) doi: 10.1016/j.ultrasmedbio.2014.05.008
128
Fan Xia, Xiaorui Yao, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00099
129
Giuseppina Palladini, Laura G. Di Pasqua, Clarissa Berardo, Veronica Siciliano, Plinio Richelmi, Stefano Perlini, Andrea Ferrigno, Mariapia Vairetti. Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/5413461
130
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11) doi: 10.3390/nu11112586
131
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2) doi: 10.34172/mejdd.2022.270
132
Thing-Fong Tzeng, Shorong-Shii Liou, I.-Min Liu. 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation and fibrogenesis. RSC Adv. 2014; 4(106) doi: 10.1039/C4RA12030B
133
Hong Xu, Gao-Feng Chen, Yu-Shui Ma, Hong-Wei Zhang, Yang Zhou, Guang-Hui Liu, Dong-Ya Chen, Jian Ping, Yi-Hui Liu, Xin Mou, Da Fu. Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00216
134
Venkat R Pannala, Archana Hari, Mohamed Diwan M AbdulHameed, Michele R Balik-Meisner, Deepak Mav, Dhiral P Phadke, Elizabeth H Scholl, Ruchir R Shah, Scott S Auerbach, Anders Wallqvist. Quantifying liver-toxic responses from dose-dependent chemical exposures using a rat genome-scale metabolic model. Toxicological Sciences 2025;  doi: 10.1093/toxsci/kfaf005
135
Martin J. J. Ronis, Kelly E. Mercer, Brenda Gannon, Bridgette Engi, Piotr Zimniak, Colin T. Shearn, David J. Orlicky, Emanuele Albano, Thomas M. Badger, Dennis R. Petersen. Increased 4-hydroxynonenal protein adducts in male GSTA4–4/PPAR-α double knockout mice enhance injury during early stages of alcoholic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(5) doi: 10.1152/ajpgi.00154.2014
136
Deise Jaqueline Ströher, Micaela Federizzi de Oliveira, Patrícia Martinez-Oliveira, Bruna Cocco Pilar, Márcia Denise Pavanelo Cattelan, Eliseu Rodrigues, Kalyne Bertolin, Paulo Bayard Dias Gonçalves, Jacqueline da Costa Escobar Piccoli, Vanusa Manfredini. Virgin Coconut Oil Associated with High-Fat Diet Induces Metabolic Dysfunctions, Adipose Inflammation, and Hepatic Lipid Accumulation. Journal of Medicinal Food 2020; 23(7) doi: 10.1089/jmf.2019.0172
137
Shuqin Wang, Xue Li, Weizhe Xu, Jing Gao, Yin Wang, Xiaoyuan Jia, Gongchu Li, Qiuwei Pan, Kan Chen. Amelioration of Hepatic Steatosis by the Androgen Receptor Inhibitor EPI-001 in Mice and Human Hepatic Cells Is Associated with the Inhibition of CYP2E1. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232416063
138
Muxi Qi, Guoliang Yin, Shujun Wang, Na Xie, Xin Zhang, Wenfei Yu, Decheng Meng, Linya Wang, Yuqing Sun, Hongshuai Liu, Wenying Jiang, Di Liu, Fengxia Zhang. Diosgenin inhibits necroptosis to alleviate NAFLD by blocking the RIPK1/RIPK3/MLKL pathway.. The Journal of Nutritional Biochemistry 2026;  doi: 10.1016/j.jnutbio.2026.110449
139
Hanlin Shi, Xiaohong Duan, Jingcheng Dong, Yanyan Tao, Yang Lei. RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway. Journal of Ethnopharmacology 2024; 326 doi: 10.1016/j.jep.2024.117963
140
Xiaorui Yao, Fan Xia, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. Journal of Ethnopharmacology 2018; 212 doi: 10.1016/j.jep.2017.09.016
141
Azam Moslehi, Tahereh Komeili-Movahed. The Effects of Rosmarinic Acid on the Liver Fibrosis Induced by Non-alcoholic Steatohepatitis in Male Mice. Qom Univ Med Sci J 2021; 15(1) doi: 10.52547/qums.15.1.2
142
Rasha A. Al-Shali, Wafaa S. Ramadan. Germinated barley downregulates hepatic stearoyl-CoA desaturase-1 enzyme gene expression in a hepatic steatohepatitis rat model. Anatomical Science International 2020; 95(4) doi: 10.1007/s12565-020-00546-y
143
Lidianys María Lewis Lujan, Natalia Madrid Molina, Diego Emmanuel Guerrero-Magaña, Annette Pulcherie Iloki Lewis, Marisol Reséndiz Zarazúa, Andres Enrique Rivera Vizcarra, María del Carmen Carranza Peña, Karla Isabel Moreno López, Cesar Benjamin Otero Leon, Simon Bernard Iloki-Assanga. Role of excessive fructose consumption on liver health. Clinical Nutrition Open Science 2026; 65 doi: 10.1016/j.nutos.2025.12.007
144
Felix F. Schmidt, Dajana Lichtenstein, Hannes Planatscher, Almut Mentz, Joern Kalinowski, Andreas E. Steinhilber, Thomas O. Joos, Albert Braeuning, Oliver Pötz. Pesticide mixture effects on liver protein abundance in HepaRG cells. Toxicology 2021; 458 doi: 10.1016/j.tox.2021.152839
145
Hualing Wang, Xinyu Liu, Chunyi Wang, Shishuang Yu, Xiuli Yang, Xiyu Cao, Maocai Luo, Shiwei Liu, Chuantao Zhang. Natural active botanical metabolites: targeting AMPK signaling pathway to treat metabolic dysfunction-associated fatty liver disease. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1611400
146
Yoshitaka Kondo, Hirofumi Masutomi, Yoshihiro Noda, Yusuke Ozawa, Keita Takahashi, Setsuko Handa, Naoki Maruyama, Takahiko Shimizu, Akihito Ishigami. Senescence marker protein‐30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis. FEBS Open Bio 2014; 4(1) doi: 10.1016/j.fob.2014.05.003
147
Daniel Leclerc, Karen E. Christensen, Alaina M. Reagan, Vafa Keser, Yan Luan, Olga V. Malysheva, Brandi Wasek, Teodoro Bottiglieri, Marie A. Caudill, Gareth R. Howell, Rima Rozen. Folate Deficiency and/or the Genetic Variant Mthfr677C >T Can Drive Hepatic Fibrosis or Steatosis in Mice, in a Sex‐Specific Manner. Molecular Nutrition & Food Research 2024; 68(5) doi: 10.1002/mnfr.202300355
148
Roberto Catanzaro, Federica Calabrese, Sergio Occhipinti, Maria Grazia Anzalone, Angelo Italia, Michele Milazzo, Francesco Marotta. Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux Symptoms. Digestive Diseases and Sciences 2014; 59(8) doi: 10.1007/s10620-014-3113-7
149
Yangyue Ni, Mengwen Huang, Shiyang Chen, Shihui Wang, Jianfeng Chen. Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications. Acta Biochimica et Biophysica Sinica 2024; 56(11) doi: 10.3724/abbs.2024149
150
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232415489
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.